What is Arlington Scientific?
Arlington Scientific operates as a specialized manufacturer and developer of in-vitro diagnostic test kits and high-throughput automated testing systems. By focusing on niche diagnostic areas such as the ASI Evolution Automated RPR Syphilis Analyzer and non-mammalian blocking buffers, the company provides essential infrastructure for healthcare providers. Their market position is defined by a commitment to diagnostic precision and the streamlining of laboratory workflows, ensuring that clinical facilities can maintain high-volume testing standards without compromising on accuracy or regulatory compliance.
How much funding has Arlington Scientific raised?
Arlington Scientific has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Arlington Scientific
PPP
Public-Private Partnership
What's next for Arlington Scientific?
With this latest round of financing, Arlington Scientific is well-positioned to scale its operational footprint and accelerate the deployment of its automated diagnostic platforms. The strategic focus will likely shift toward expanding market penetration in underserved regions and enhancing the R&D pipeline for next-generation serology assays. As the company navigates this late-stage growth phase, the integration of advanced automation will be pivotal in maintaining its competitive edge against larger diagnostic conglomerates, ultimately driving long-term value for stakeholders and improving patient outcomes through more efficient screening protocols.
See full Arlington Scientific company page
